FG-B901

DRUG2 trials

Sponsors

FutureGen Biopharmaceutical (Beijing) Co., Ltd

Conditions

Claudin 18.2Solid TumorSolid Tumor Malignancies

Phase 1

A Study of FG-B901 Monotherapy or Combination With Chemotherapy in Advanced or Metastatic Solid Tumors

Not yet recruitingNCT07623707

FutureGen Biopharmaceutical (Beijing) Co., LtdSolid Tumor

Start: 2026-07-01End: 2029-07-01Target: 264Updated: 2026-06-03

A Phase I/II Study of FG-M108 Plus FG-B901 in Advanced CLDN18.2-Positive Solid Tumors

Not yet recruitingNCT07704866

FutureGen Biopharmaceutical (Beijing) Co., LtdClaudin 18.2, Solid Tumor Malignancies

Start: 2026-07-30End: 2029-02-28Target: 120Updated: 2026-07-15